Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 4/20 | 0.53 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.49 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578339 | 1.00 | CETP (0.53) | CETPS1PR3S1PR2S1PR4S1PR1 | |
| SCHEMBL578336 | 0.98 | CETP (0.51) | CETPS1PR3S1PR2S1PR4S1PR1 | |
| SCHEMBL8733377 | 0.93 | TSHR (0.52) | CETPS1PR3S1PR2S1PR4S1PR1 | |
| SCHEMBL2333456 | 0.86 | TSHR (0.55) | CETPS1PR3S1PR2S1PR4S1PR1 | |
| SCHEMBL26985983 | 0.86 | S1PR3 (0.41) | CETPS1PR3S1PR2S1PR4S1PR1 | |
| SCHEMBL24487094 | 0.83 | TSHR (0.54) | CETPS1PR3S1PR2S1PR4S1PR1 | |
| SCHEMBL4238988 | 0.83 | TSHR (0.53) | CETPTSHRL3MBTL1TDP1EPHX2 | |
| SCHEMBL20958119 | 0.83 | TSHR (0.52) | CETPTSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL20958153 | 0.83 | TSHR (0.52) | CETPTSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL9011734 | 0.82 | TSHR (0.67) | TSHRL3MBTL1TDP1EPHX2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | EFNA1, PHOSPHO1, EPHA6 | CETP 4728/4885S1PR3 1996/4885S1PR2 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.